Join to View Full Profile
225 E Chicago AveChicago, IL 60611
Phone+1 312-227-4000
Fax+1 615-936-1767
Dr. Zarnegar-Lumley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2017
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2011 - 2014
Georgetown University School of MedicineClass of 2011
Certifications & Licensure
IL State Medical License 2023 - 2026
TN State Medical License 2017 - 2024
NY State Medical License 2014 - 2019
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients Start of enrollment: 2016 Oct 01
- Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation Start of enrollment: 2023 Aug 14
Publications & Presentations
PubMed
- 1 citationsComprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents.Kathryn L McElhinney, Samantha K McLean, Sara Zarnegar-Lumley, Monica M Laronda, Erin E Rowell
Pediatric Blood & Cancer. 2024-10-01 - 3 citationsBosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang
Journal of Clinical Oncology. 2024-03-01 - 23 citationsCharacteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun
Blood Advances. 2023-10-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
